LYPD1 Activators
LYPD1 Activators are chemical compounds that indirectly enhance the functional activity of LYPD1 through various signaling mechanisms. Forskolin, by raising cAMP levels, can indirectly increase LYPD1's role in cellular processes by activating PKA, which may phosphorylate proteins associated with cell migration and adhesion, where LYPD1 is implicated. Similarly, IBMX, by inhibiting the degradation of cAMP, and Dibutyryl cAMP, a cAMP analog, can lead to an enhancement of LYPD1 through PKA-mediated signaling. PMA, through PKC activation, and Sphingosine-1-phosphate, by engaging S1P receptors and activating downstream signaling like PI3K/Akt, provide potential routes for enhancing LYPD1's activities in cell migration and adhesion. Furthermore, Epigallocatechin gallate, by its kinase inhibitory action may shift cellular signaling to favor LYPD1's involvement in similar processes.
Thapsigargin and A23187 both work through altering calcium signaling; the former by inhibiting SERCA, and the latter by acting as a calcium ionophore, both potentially enhancing LYPD1 activity through calcium-dependent signaling pathways. Genistein, as a tyrosine kinase inhibitor, allows for the potential enhancement of LYPD1 activity by reducing competition from tyrosine kinase signaling, which might otherwise suppress pathways where LYPD1 is involved. Staurosporine, albeit a broad-spectrum kinase inhibitor, could lead to selective enhancement of LYPD1 pathways by mitigating the inhibition exerted by specific kinases on processes related to LYPD1's role in cell adhesion and migration.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylate cyclase, leading to increased cAMP levels, which in turn can enhance LYPD1 activity by promoting cAMP-dependent protein kinase (PKA) signaling that is known to phosphorylate proteins related to cell migration and adhesion, processes in which LYPD1 is involved. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a non-selective inhibitor of phosphodiesterases, which increases cAMP levels by preventing its degradation, thereby potentially enhancing LYPD1 activity by similar PKA-mediated pathways as Forskolin. | ||||||
Adenosine 3′,5′-cyclic monophosphate | 60-92-4 | sc-217584 sc-217584A sc-217584B sc-217584C sc-217584D sc-217584E | 100 mg 250 mg 5 g 10 g 25 g 50 g | $116.00 $179.00 $265.00 $369.00 $629.00 $1150.00 | ||
Dibutyryl cAMP is a cell-permeable cAMP analog that directly activates PKA, possibly leading to enhanced LYPD1 activity by promoting signaling pathways associated with cell adhesion. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC) which may lead to the enhancement of LYPD1 functional activity through PKC-mediated signaling pathways implicated in cellular processes such as migration and adhesion. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
Sphingosine-1-phosphate (S1P) engages S1P receptors, which can activate intracellular signaling cascades such as PI3K/Akt pathway, potentially leading to the enhancement of LYPD1 activity in migration and adhesion. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
Epigallocatechin gallate (EGCG) is a kinase inhibitor that could enhance LYPD1 activity by inhibiting competitive signal transduction pathways, thus potentially allowing cell adhesion processes where LYPD1 is a factor to be more prominent. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by blocking the sarcoplasmic/endoplasmic reticulum Ca2+ ATPase (SERCA), potentially leading to the activation of calcium-dependent pathways that enhance LYPD1 activity. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that increases intracellular calcium levels, which could lead to the enhancement of LYPD1 activity by activating calcium-dependent signaling mechanisms. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a tyrosine kinase inhibitor which may enhance LYPD1 activity by inhibiting competitive signaling pathways, potentially leading to increased cell-cell adhesion where LYPD1 is involved. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a protein kinase inhibitor that may selectively enhance LYPD1 activity by reducing the activity of kinases that negatively regulate pathways associated with LYPD1. | ||||||